Nursing

Chronic Pain:

Can be constant or intermittent and lasts longer than 3 months and persists beyond tissue healing. Physiological responses don't usually increase vital signs in some cases they can be lower than normal. Creates stiffness & decreases ROM. Behavioral responses in patients can become depressed, lethargic, and discouraged. 4's: shooting, stiffness, squeezing, & stinging. Pain medication follows the WHO ladder; non-opioids (NSAIDs (Ibuprofen), Antipyretic/Analgesic (Acetaminophen)) & if needed opioids (Opioid/APAP (Hydrocodone-Acetaminophen), Opioid Agonist (Morphine)). Take medications PRN prior to activity.

Neuropathic Pain:

- Pathophys: occurs due to radiculopathy when nerves are pinched (Sciatica).

- Risk factors: nerve trauma/injury (surgery, amputation, nerve compression), vitamin B12 deficiency, diabetes mellitus (diabetic neuropathy), multiple sclerosis, stroke, spinal cord injury.

- Clinical manifest: burning, stabbing, shooting, electric/shock pain, tingling, numbness, pins & needles, sensitivity to touch, hyperalgesia (inc sensitivity to pain), spontaneous pain (w/out a clear stimulus), & allodynia (pain from non-painful stimuli).

- Labs & diagnostics with results: MRI/CT (spinal cord compression, tumor, stroke), electromyography EMG (slowed conduction velocity, abnormal spontaneous activity), quantitative sensory testing QST (increased sensitivity to pain, temp changes), vitamin B12 blood test (low in nutritional deficiency neuropathies).

- Med/Surg manage:

med: anticonvulsant & antidepressant drugs, NSAIDs, & narcotics (extreme).

surg: spinal cord fusion/ stimulation, or nerve decompression surgery.

- Complications: changes in deep tendon reflexes, limited mobility, sleep loss, stress, & depression.

- Medications: pregabalin & gabapentin

- Nursing process:

A: assess pain description, check vital signs, functional limitations, sleep patterns, and mood changes.

D: chronic pain related to nerve dysfunction as evidenced by pt report of burning & shooting pain. impaired physical mobility related to pain & discomfort. disturbed sleep pattern related to persistent pain.

P: pt will report a decreased pain level in one week, demonstrate improved sleep quality within a month, & verbalize two coping strategies for pain management.

I: administer prescribed meds & monitor side effects, encourage heat/cold therapy, teach pt about med adherence, exercise, and lifestyle modifications.

Evaluate: pain levels, functionality, & mental health.

Osteoarthritis (Chronic Pain):

1.     Explain the pathophysiology of osteoarthritis.

Osteoarthritis (OA) is a chronic, degenerative joint disease caused by the gradual breakdown of cartilage in weight-bearing joints.

Process:

1.     Cartilage wears down, reducing joint cushioning.

2.     Bones rub together, causing pain, stiffness, and inflammation.

3.     Bone spurs (osteophytes) form, limiting movement.

4.     Decreased synovial fluid leads to stiffness and crepitus (grinding sound).

2.     Identify risk factors for development of osteoarthritis.

1.Age & Gender

·      Older adults (cartilage naturally breaks down with age).

·      More common in women, especially after menopause.

2. Joint Overuse & Injuries

·      Repetitive joint movement (e.g., athletes, physical laborers).

·      Previous joint injuries (fractures, ligament tears).

3. Obesity

·      Extra weight adds stress to weight-bearing joints (knees, hips).

·      Fat cells release inflammatory chemicals that worsen cartilage damage.

4. Genetics & Family History

·      Some people inherit weaker cartilage or joint structures, increasing OA risk.

5. Other Health Conditions

·      Diabetes & metabolic disorders (affect cartilage health).

·      Joint malalignment or deformities (e.g., bowlegs, hip dysplasia).

Bottom Line: Aging, joint stress, obesity, genetics, and medical conditions contribute to OA development. Maintaining a healthy weight, staying active, and protecting joints can help reduce risk.

3.     Describe the signs and symptoms of chronic pain in osteoarthritis.

1.Pain & Stiffness

·      Pain lasts more than 3 months and worsens with movement.

·      Stiffness after rest (especially in the morning or after inactivity).

2.Joint Changes & Limited Mobility

·      Decreased range of motion (ROM) (difficulty bending, walking, or gripping).

·      Joint enlargement/swelling due to inflammation.

·      Crepitus (grinding or cracking sound) with movement.

3.Pain Pattern

·      Worsens after activity but improves with rest.

·      May flare up due to weather changes or stress.

4.Chronic Discomfort & Emotional Effects

·      Persistent aching affecting daily tasks.

·      Can lead to fatigue, depression, and anxiety.

Summary: Chronic OA pain causes stiffness, swelling, and limited mobility, worsens with movement, and affects daily activities. Managing pain through medications, physical therapy, and joint protection is key to maintaining function.

4.     Identify changes in laboratory tests and diagnostic results in osteoarthritis.

1.Imaging Tests (Primary Diagnostic Tools)

·      X-rays – Show joint space narrowing, bone spurs (osteophytes), and cartilage loss.

·      CT Scan & MRI – Provide detailed images of cartilage, bone, and soft tissue damage (used in severe or unclear cases).

2. Laboratory Tests (Used to Rule Out Other Conditions)

·      No specific blood test for OA, but some tests help exclude rheumatoid arthritis or infections:

·      ESR (Erythrocyte Sedimentation Rate) & CRP (C-Reactive Protein) – Usually normal in OA but elevated in inflammatory conditions like rheumatoid arthritis.

·      Joint Fluid Analysis – Used to rule out infection or gout by checking for crystals or signs of inflammation.

Summary: X-rays, CT, and MRI confirm bone and cartilage damage in OA. Lab tests are normal but may be used to rule out other conditions like rheumatoid arthritis or infection.

5.     Discuss medical/surgical management of patients with osteoarthritis.

1.Medical (Non-Surgical) Management

Medications:

·      Pain relievers: Acetaminophen for mild pain.

·      NSAIDs (Nonsteroidal Anti-Inflammatory Drugs): Ibuprofen, naproxen for pain & inflammation.

·      Topical treatments: Gels or creams for localized pain relief.

·      Antidepressants: May help with chronic pain management. (cymbalta-duloxetine)

·      Steroid injections: Reduce inflammation in severe cases.

Nonpharmacological Interventions:

·      Heat & cold therapy: Reduces pain and stiffness.

·      Joint protection devices: Braces, splints to support weak joints.

·      Physical activity: Low-impact exercises (swimming, walking) maintain mobility.

·      Weight management: Reduces stress on joints.

·      Acupuncture & integrative therapies for additional pain relief.

2. Surgical Management (For Severe Cases)

·      Joint Replacement (Arthroplasty): Used when pain and disability become severe. Common sites: Hip & knee replacements. 

·      Other Surgical Procedures:

·      Osteotomy: Realigns the joint to reduce pressure.

·      Arthroscopy: Minimally invasive procedure to remove damaged cartilage (less common for OA).

Summary: Mild to moderate OA is managed with pain relievers, lifestyle changes, and therapy. Severe cases may require joint replacement surgery.

6.     Apply all steps of the nursing process in the care of a patient with osteoarthritis.

1.Assessment (Gathering Patient Data)

·      Pain assessment – Use pain scale (0-10), location, duration, and aggravating factors.

·      Physical exam – Observe joint swelling, stiffness, limited range of motion (ROM), crepitus.

·      Functional ability – Assess mobility, ability to perform ADLs (activities of daily living).

·      Emotional well-being – Evaluate stress, anxiety, depression due to chronic pain.

2. Diagnosis (Identifying Nursing Problems) Common nursing diagnoses for OA patients:

·      Chronic pain related to joint degeneration.

·      Impaired physical mobility due to joint stiffness and pain.

·      Self-care deficit related to decreased range of motion.

·      Activity intolerance due to joint discomfort.

3. Planning (Setting Patient Goals & Outcomes)

·      Reduce pain to a manageable level (e.g., pain scale of ≤ 3/10).

·      Improve mobility and function (e.g., patient will walk 10 minutes daily with minimal discomfort).

·      Promote independence in performing ADLs.

·      Prevent further joint damage through lifestyle modifications.

4. Implementation (Nursing Interventions)

Pharmacological Interventions

·      Administer NSAIDs, acetaminophen, Cymbalta, or steroid injections as prescribed.

·      Educate about medication use, side effects, and safety.

Nonpharmacological Interventions

·      Heat & cold therapy to reduce pain and stiffness.

·      Encourage low-impact exercise (e.g., swimming, walking) to maintain joint function.

·      Weight management & nutrition education to reduce joint stress.

·      Joint protection techniques (e.g., assistive devices, proper body mechanics).

Patient Education & Emotional Support

·      Teach the importance of staying active while avoiding overuse.

·      Encourage pain coping strategies (relaxation techniques, mindfulness).

5. Evaluation (Assessing Effectiveness of Care)

·      Has pain improved? (Assess pain levels after interventions).

·      Is the patient more mobile? (Check for improved ROM and ability to perform daily activities).

·      Are treatment goals being met? (If not, adjust medications or therapy plans).

Summary: Assess pain, mobility, and emotional well-being. Diagnose based on functional limitations and pain level. Plan realistic goals to improve comfort and mobility. Implement medication, therapy, and lifestyle changes. Evaluate progress and adjust interventions as needed.

7.     Describe the complications of osteoarthritis.

1.Physical Complications

·      Joint Damage & Deformity – Severe cartilage loss leads to bone-on-bone friction, causing joint misalignment and deformities.

·      Limited Mobility – Stiffness and pain reduce range of motion (ROM), making movement difficult.

·      Muscle Weakness – Decreased activity leads to muscle atrophy, worsening joint instability.

2. Functional & Lifestyle Complications

·      Loss of Independence – Difficulty with daily activities (ADLs), such as dressing, cooking, or walking.

·      Increased Fall Risk – Weak joints and limited mobility increase the likelihood of falls and fractures.

3. Emotional & Psychological Complications

·      Chronic Pain & Fatigue – Persistent pain can lead to sleep disturbances and exhaustion.

·      Depression & Anxiety – Reduced quality of life due to chronic discomfort and mobility limitations.

4. Long-Term Health Risks

·      Weight Gain & Obesity – Reduced activity can lead to weight gain, worsening joint stress.

·      Cardiovascular Issues – Less mobility increases the risk of heart disease and poor circulation.

Summary: Osteoarthritis can cause joint deformities, mobility loss, muscle weakness, emotional distress, and increased health risks. Managing symptoms with medications, exercise, and lifestyle changes helps prevent complications.

8.     Discuss the psychological effect of chronic pain on the patient.

1.Emotional Effects

·      Anxiety & Fear – Patients may fear movement or worsening pain, leading to avoidance of activities.

·      Depression & Hopelessness – Constant pain can cause feelings of despair, sadness, and loss of enjoyment in life.

2. Cognitive Effects

·      Difficulty Concentrating – Persistent pain affects focus and decision-making.

·      Sleep Disturbances – Pain disrupts sleep quality, leading to fatigue, irritability, and cognitive decline.

3. Social & Behavioral Effects

·      Social Withdrawal – Patients may avoid social interactions due to pain or reduced mobility.

·      Loss of Independence – Struggling with daily activities (ADLs) can lead to frustration and reliance on others.

4. Impact on Stress & Coping

·      Increased Stress Levels – Chronic pain triggers a constant stress response, worsening overall health.

·      Coping Difficulties – Some patients develop unhealthy coping mechanisms (e.g., substance use, isolation).

Summary: Chronic pain causes stress, anxiety, depression, sleep problems, and social withdrawal, reducing quality of life. Pain management, emotional support, and therapy can help improve well-being.

9.     Compare and contrast medications utilized for pain management in patients experiencing chronic versus acute pain utilizing the WHO ladder.Key Differences:

·      Acute pain is treated with short-term medications like NSAIDs, opioids, and steroids.

·      Chronic pain requires long-term management, often using adjuvants (Cymbalta, Gabapentin), injections, and lifestyle changes.

       Key Similarities:

·      Both use the WHO Pain Ladder approach, starting with mild pain meds and increasing if needed.

·      Multimodal pain management (drug + non-drug therapies) is recommended for both.

Summary: Acute pain is managed with NSAIDs and short-term opioids, while chronic pain requires long-acting opioids, adjuvants, and lifestyle modifications. The WHO Pain Ladder ensures safe, stepwise pain relief.

Degenerative Disk Disease (Neuropathic Pain):

1.     Explain the pathophysiology of degenerative disk disease.

Degenerative Disk Disease (DDD) is a condition where the spinal discs gradually break down due to aging, wear-and-tear, or injury, leading to chronic pain and reduced mobility. Pathophysiology Process:

1.Disc Dehydration & Loss of Cushioning

·      Spinal discs contain gel-like material (nucleus pulposus) that provides shock absorption.

·      With age, the discs lose water content, reducing their ability to cushion the spine.

2.Disc Thinning & Weakness

·      As the disc shrinks, vertebrae move closer together, increasing pressure on nerves.

·      Loss of disc height can lead to spinal instability.

3.Tear Formation & Inflammation

·      The outer layer of the disc (annulus fibrosus) develops cracks or tears.

·      This causes inflammation and pain, especially with movement.

4.Bone Spur Formation (Osteophytes)

·      The body compensates for disc damage by forming bone spurs, which can compress spinal nerves, leading to neuropathic pain, tingling, and numbness.

5.Progression to Nerve Compression & Chronic Pain

·      If nerve roots become pinched, conditions like sciatica (radiating leg pain) can develop.

·      Over time, muscle weakness and mobility issues may occur due to chronic nerve irritation.

Summary: Degenerative Disk Disease occurs when spinal discs lose water, weaken, and shrink, leading to nerve compression, pain, and reduced mobility. The condition worsens over time and may require pain management, physical therapy, or surgery.

2.     Identify risk factors for development of degenerative disk disease.

1.Aging (Primary Risk Factor)

·      Discs naturally lose water content and flexibility over time, making them more prone to damage.

2. Repetitive Stress & Spinal Overuse

·       Heavy lifting, twisting, and bending (common in physical labor jobs).

·       High-impact activities (e.g., certain sports) put strain on spinal discs.

3. Obesity & Excess Weight

·      Extra stress on the spine accelerates disc degeneration.

4. Genetics & Family History

·      Some people inherit weaker spinal discs, making them more prone to early degeneration.

5. Smoking & Poor Circulation

·      Reduces oxygen supply to spinal discs, slowing healing and repair.

6. Spinal Injuries & Trauma

·      Past injuries (car accidents, falls, or fractures) can accelerate disc damage.

7. Sedentary Lifestyle & Poor Posture

Lack of movement weakens spinal support muscles, increasing stress on discs.

Summary: Aging, repetitive stress, obesity, genetics, smoking, injuries, and poor posture all increase the risk of Degenerative Disk Disease. Maintaining good posture, a healthy weight, and staying active can help prevent or slow its progression.

3.     Describe the signs and symptoms of degenerative disk disease.

1.Pain Symptoms

·      Chronic back or neck pain (depending on the affected area).

·      Pain worsens with movement (bending, twisting, lifting).

·      Pain improves with rest or changing positions (e.g., lying down).

·      Radiating pain (e.g., sciatica – pain traveling down the leg).

2. Neurological Symptoms (When Nerve Compression Occurs)

·      Burning, tingling, or numbness in the arms, legs, or affected area.

·      Electric shock-like sensations along the spine or extremities.

·      Weakness in muscles due to nerve involvement.

3. Mobility & Functional Limitations

·      Stiffness and reduced flexibility in the back or neck.

·      Difficulty standing or sitting for long periods.

·      Increased pain with prolonged activity.

4. Long-Term Effects

·      Chronic nerve compression can lead to decreased deep tendon reflexes.

·      Severe cases may require surgery if pain and mobility worsen significantly.

Summary: DDD causes chronic back/neck pain, nerve symptoms (burning, tingling, numbness), and mobility issues. Pain worsens with activity but improves with rest. Severe cases can lead to nerve compression and weakness.

4.     Identify changes in laboratory tests and diagnostic results in degenerative disk disease.

1.Imaging Tests (Primary Diagnostic Tools) 

MRI (Magnetic Resonance Imaging)

·      Best test for visualizing disc degeneration.

·      Shows disc thinning, herniation, and nerve compression.

X-rays

·      Reveals loss of disc height and bone spur formation (osteophytes).

·      Can detect spinal misalignment or joint narrowing. 

CT Scan (Computed Tomography)

·      Provides detailed images of bones and spinal structures.

·      Used if MRI is unavailable or contraindicated.

2. Laboratory Tests (Used to Rule Out Other Conditions)

·      No specific blood test for DDD.

·      ESR (Erythrocyte Sedimentation Rate) & CRP (C-Reactive Protein) may be used to rule out infections or inflammatory conditions like rheumatoid arthritis.

Summary: DDD is diagnosed mainly through MRI and X-rays, which show disc thinning, bone spurs, and nerve compression. Lab tests are used only to exclude other diseases.

5.     Discuss medical/surgical management of patients with degenerative disk disease.

1.Medical (Non-Surgical) Management

Medications:

·      NSAIDs (Ibuprofen, Naproxen) – Reduce pain and inflammation.

·      Acetaminophen – For mild pain relief.

·      Muscle Relaxants – Help relieve muscle spasms.

·      Anticonvulsants (Gabapentin, Pregabalin) – Used for nerve pain relief.

·      Antidepressants (Cymbalta, Amitriptyline) – Help with chronic pain management.

·      Steroid Injections – Reduce inflammation around the spinal nerves.

Nonpharmacological Interventions:

·      Physical Therapy – Strengthens muscles to support the spine.

·      Heat & Cold Therapy – Helps with pain and stiffness.

·      Weight Management – Reduces stress on spinal discs.

·      Activity Modification & Ergonomic Adjustments – Avoiding heavy lifting, improving posture.

2. Surgical Management (For Severe Cases) 

·      Discectomy- Removes part of the damaged disc that is pressing on nerves. 

·      Spinal Fusion- Joins two vertebrae together to stabilize the spine and reduce pain.

·      Artificial Disc Replacement- Replaces the damaged disc with an artificial one to maintain mobility.

Summary: Mild to moderate DDD is treated with medications (NSAIDs, muscle relaxants, nerve pain meds), physical therapy, and lifestyle changes. Severe cases may require surgery (discectomy, spinal fusion, or disc replacement) to relieve nerve compression and restore function.

6.     Apply all steps of the nursing process in the care of a patient with degenerative disk disease.

1.Assessment (Gathering Patient Data)

·      Pain assessment – Location, severity (0-10 pain scale), aggravating & relieving factors.

·      Physical exam – Observe posture, mobility, range of motion (ROM), muscle strength.

·      Neurological symptoms – Check for numbness, tingling, burning pain, or weakness.

·      Functional limitations – Evaluate difficulty with daily activities (ADLs), walking, sitting, standing.

2. Diagnosis (Identifying Nursing Problems) Common nursing diagnoses for DDD patients:

·      Chronic pain related to nerve compression.

·      Impaired physical mobility due to stiffness and pain.

·      Activity intolerance related to discomfort with movement.

·      Risk for injury due to weakness and instability.

3. Planning (Setting Patient Goals & Outcomes)

·      Reduce pain to a manageable level (e.g., pain ≤ 3/10).

·      Improve mobility and function (e.g., walk short distances with minimal discomfort).

·      Promote independence in performing ADLs.

·      Prevent further nerve damage through proper interventions.

4. Implementation (Nursing Interventions) 

Pharmacological Interventions:

·      Administer NSAIDs, muscle relaxants, or nerve pain medications as prescribed.

·      Educate about medication use, side effects, and proper dosing. 

Nonpharmacological Comfort Strategies:

·      Physical therapy & gentle exercise to strengthen muscles.

·      Heat & cold therapy to reduce pain and inflammation.

·      Positioning adjustments & ergonomic support (e.g., proper sitting posture, lumbar support).

·      Encourage weight management & lifestyle changes to reduce spinal stress. 

Patient Education & Emotional Support:

·      Teach body mechanics to prevent further spinal strain.

·      Educate on activity modifications to avoid worsening pain.

·      Provide emotional reassurance, as chronic pain can cause anxiety and depression.

5. Evaluation (Assessing Effectiveness of Care)

·      Has pain improved? (Reassess pain levels after interventions).

·      Is the patient more mobile? (Check for improved range of motion and ability to perform daily tasks).

·      Are treatment goals being met? (If not, adjust interventions accordingly).

Summary: Assess pain, mobility, and neurological symptoms. Diagnose based on pain level, movement restrictions, and nerve involvement. Plan realistic goals for pain relief and improved function. Implement medications, physical therapy, positioning, and patient education. Evaluate progress and adjust interventions as needed.

7.     Describe the complications of degenerative disk disease.

1.Chronic Pain & Reduced Mobility

·      Persistent back or neck pain that worsens over time.

·      Limited range of motion (ROM), making daily activities difficult.

2. Nerve Compression & Neurological Issues

·      Radiculopathy (Pinched Nerve) – Causes burning, tingling, numbness, or weakness in arms or legs.

·      Sciatica – Pain radiating down the leg due to nerve compression in the lower spine.

·      Loss of Deep Tendon Reflexes – If nerve damage progresses.

3. Spinal Instability & Deformities

·      Herniated (Bulging) Discs – Discs protrude and press on nerves, increasing pain and dysfunction.

·      Spinal Stenosis – Narrowing of the spinal canal, leading to nerve pressure and weakness.

·      Spondylolisthesis – A vertebra slips out of place, causing spinal misalignment.

4. Functional Limitations & Emotional Effects

·      Difficulty walking, sitting, or standing for long periods.

·      Increased risk of falls & injuries due to weakness.

·      Depression & anxiety from chronic pain and disability.

Summary: DDD can lead to chronic pain, nerve compression (sciatica, radiculopathy), spinal instability, and mobility issues. Severe cases may require surgical intervention. Early treatment can help prevent complications.

Total Joint Arthroplasty (Post-Operative Acute Pain):

1.     Apply all steps of the nursing process in caring for a patient experiencing post-operative pain. 

A: assessment

·      Pain assessment – Use pain scale (0-10), PQRST method to evaluate location, intensity, and characteristics.

·      Vital signs – Increased heart rate, blood pressure, respiratory rate due to pain.

·      Observe nonverbal signs – Grimacing, guarding, restlessness, moaning, limited movement.

·      Assess surgical site – Check for swelling, redness, drainage, and signs of infection.

·      Monitor for complications – Watch for DVT (deep vein thrombosis), bleeding, and impaired mobility.

D:Diagnosis Common nursing diagnoses for post-op TJA pain:

·      Acute pain related to surgical trauma.

·      Impaired physical mobility due to pain and swelling.

·      Risk for infection due to surgical wound.

·      Risk for delayed recovery related to ineffective pain control.

P:Planning

·      Reduce pain to a manageable level (e.g., pain ≤ 3/10).

·      Improve mobility (e.g., sit up, stand, or walk a few steps within 24 hours post-op).

·      Prevent complications (infection, blood clots, delayed healing).

·      Promote patient comfort and satisfaction.

I: implementing

Pharmacological Pain Management:

·      Administer scheduled & PRN pain medications as ordered.

·      IV opioids (first 24-48 hrs), then PO opioids/NSAIDs as tolerated.

·      Monitor for side effects (respiratory depression, sedation, nausea).

·      Patient-controlled analgesia (PCA) if prescribed. 

Nonpharmacological Pain Relief:

·      Positioning & Elevation – Support joint alignment, use pillows.

·      Ice therapy – Reduces swelling and pain.

·      Distraction techniques – Music, relaxation exercises. 

Early Mobility & Post-Op Care:

·      Encourage deep breathing & coughing to prevent pneumonia.

·      Assist with early ambulation (PT or walker-assisted movement).

·      Monitor for DVT signs (calf pain, swelling, warmth).

·      Educate on wound care and infection prevention.

E: Evaluate

·      Has pain improved? (Check pain level after interventions).

·      Can the patient move comfortably? (Assess ability to walk, sit, and perform ADLs).

·      Are complications being prevented? (No infection, blood clots, or respiratory issues).

·      Adjust pain management plan if needed.

Summary: Assess pain, surgical site, and vital signs. Diagnose acute pain and mobility limitations. Plan pain relief and early mobility goals. Implement medications (opioids, NSAIDs), positioning, ice therapy, and mobility support. Evaluate progress and adjust interventions to ensure recovery.

2.     Discuss nursing care for a patient with a patient-controlled analgesia (PCA) pump.

A Patient-Controlled Analgesia (PCA) pump allows patients to self-administer pain medication through an IV by pressing a button, ensuring timely and controlled pain relief.

1. Assessment (Monitoring the Patient)

·      Pain assessment – Regularly check pain levels (0-10 scale) to ensure adequate pain control.

·      Vital signs monitoring – Watch for respiratory rate, blood pressure, and sedation level to detect opioid side effects.

·      Observe for side effects – Check for nausea, vomiting, drowsiness, itching, constipation.

·      Monitor sedation & respiratory depression – Assess for slow breathing (<12 breaths/min), excessive sleepiness, low oxygen saturation.

2. Nursing Interventions & Patient Education 

Safe PCA Use:

·      Only the patient should press the PCA button (NOT family or nurses).

·      Lockout interval prevents overdose – Educate patients that repeated pressing won’t increase medication delivery.

·      Monitor for opioid side effects – Have naloxone available in case of overdose.

Pain Management & Comfort:

·      Encourage use of PCA at the first sign of pain, rather than waiting for severe pain.

·      Combine PCA with nonpharmacological pain relief (positioning, ice/heat therapy, relaxation techniques).

·      Adjust dosage or medication as needed, based on patient response and provider recommendations. 

Post-PCA Care:

·      Wean off PCA to oral medications as pain decreases.

·      Monitor for withdrawal symptoms if transitioning off opioids.

·      Educate patient on pain control methods after PCA discontinuation.

3. Evaluation (Ensuring Effective Pain Management)

·      Is the patient’s pain under control? (Check pain score).

·      Are vital signs stable? (Monitor for signs of opioid overdose or respiratory depression).

·      Does the patient understand how to use the PCA safely?

Summary: Assess pain, vital signs, and sedation levels frequently. Ensure only the patient presses the PCA button to prevent overdose. Monitor for opioid side effects and have naloxone available if needed. Wean off PCA when transitioning to oral pain meds. Proper PCA pump management ensures safe, effective pain relief while minimizing risks of opioid overdose and complications.

Procedural Pain:

1.     Apply all steps of the nursing process in caring for a patient experiencing procedural pain. 

1.Assessment (Gathering Patient Data)

·      Pain assessment – Use pain scale (0-10), PQRST method before and after the procedure.

·      Vital signs – Monitor for increased heart rate, blood pressure, and respiratory rate due to pain.

·      Observe nonverbal signs – Grimacing, guarding, restlessness, moaning, crying.

·      Anxiety levels – Patients may have fear or stress before the procedure.

2. Diagnosis (Identifying Nursing Problems)

Common nursing diagnoses for procedural pain:

·      Acute pain related to invasive procedures.

·      Anxiety related to anticipation of pain.

·      Risk for ineffective pain management due to inadequate interventions.

3. Planning (Setting Patient Goals & Outcomes)

·      Minimize pain during and after the procedure (e.g., pain ≤ 3/10).

·      Reduce anxiety and fear through education and reassurance.

·      Ensure patient comfort with effective pain relief strategies.

4. Implementation (Nursing Interventions)

 Pharmacological Pain Management:

·      Administer PRN pain medication before the procedure (IV: 5-30 minutes before, PO: 45 minutes-1 hour before).

·      Use local anesthetics (if applicable) to numb the area.

Nonpharmacological Comfort Strategies:

·      Distraction techniques – Talking, music, guided imagery.

·      Relaxation techniques – Deep breathing, mindfulness.

·      Positioning for comfort – Adjust patient’s position to minimize strain.

 Emotional Support & Education:

·      Explain the procedure to reduce fear and anxiety.

·      Reassure and encourage the patient throughout the procedure.

5. Evaluation (Assessing Effectiveness of Care)

·      Was pain relief effective? (Reassess pain score after the procedure).

·      Did the patient tolerate the procedure well? (Monitor anxiety, comfort level).

·      Were additional pain interventions needed? (Adjust treatment if pain remains uncontrolled).

Summary: Assess pain levels, vital signs, and anxiety before the procedure. Diagnose acute pain and fear related to the procedure. Plan to reduce pain and anxiety with medications and comfort measures. Implement pain relief strategies (medications, distraction, relaxation techniques). Evaluate effectiveness and adjust interventions as needed. Proper pain management improves procedural tolerance, reduces stress, and enhances patient comfort.

2.     Discuss independent nursing interventions that can be implemented to minimize pain associated with procedures and therapies.

1.Distraction Techniques

·      Talking to the patient to shift focus away from pain.

·      Listening to music or watching TV during the procedure.

·      Guided imagery – Encouraging the patient to visualize a calming scene.

2. Relaxation & Breathing Techniques

·      Deep breathing exercises to reduce anxiety and muscle tension.

·      Progressive muscle relaxation – Instructing the patient to relax different body parts one at a time.

·      Mindfulness and meditation to promote calmness.

3. Positioning & Comfort Measures

·      Adjusting the patient’s position to minimize discomfort.

·      Providing pillows or support to stabilize painful areas.

·      Encouraging movement or gentle stretching before and after procedures (if appropriate).

4. Therapeutic Touch & Environment Control

·      Gentle massage to reduce tension and improve circulation.

·      Creating a calming environment (dim lights, quiet space).

·      Reducing external stressors (minimizing noise, ensuring privacy).

5. Emotional Support & Patient Education ️

·      Explaining the procedure to reduce fear and anxiety.

·      Providing reassurance and encouragement before and during the procedure.

·      Allowing family presence for emotional support (if appropriate).

Summary: Nurses can independently reduce procedural pain through distraction, relaxation techniques, proper positioning, a calming environment, and emotional support. These nonpharmacological interventions help improve patient comfort and reduce anxiety.

3.     Discuss collaborative interventions the nurse can implement to minimize pain associated with procedures and therapies.

1.Pharmacological Pain Management (Working with Providers & Pharmacists)

·      Administer PRN pain medications before procedures (IV: 5-30 min before, PO: 45 min-1 hour before).

·      Coordinate with the provider for local anesthetics (e.g., lidocaine for injections or wound care).

·      Monitor for side effects of pain medications (e.g., respiratory depression with opioids).

2. Coordination with Physical Therapists & Specialists 

·      Schedule pain medications before physical therapy to improve tolerance.

·      Assist with positioning and movement to minimize strain on affected areas.

·      Use assistive devices (braces, splints) to reduce pain during therapy.

3. Patient Education & Support (Interdisciplinary Approach)

·      Teach patients how to use pain relief techniques (e.g., deep breathing, guided imagery).

·      Educate on medication use & side effects (collaborating with pharmacists).

·      Encourage participation in pain management programs (e.g., physical therapy, cognitive-behavioral therapy).

4. Monitoring & Communication with Healthcare Team

·      Reassess pain levels and communicate with providers for medication adjustments.

·      Report signs of complications (e.g., increased pain, infection, or poor wound healing).

·      Collaborate with wound care specialists for pain control during dressing changes.

Summary: Collaborative pain management includes medications, coordinating with therapists, educating patients, and continuous pain monitoring. Nurses work with providers, pharmacists, and physical therapists to minimize pain and improve patient comfort during procedures.

Medications: chronic & neuropathic pain (test):

1.     Opioid agonist – morphine

- Pharm class: opioid-agonist (short acting)

- Therapeutic use: used for moderate to severe pain (chronic/rare, post-op, cancer, trauma), given by IV in OR & post-op then by PO as tolerated, and used in PCA pumps for self admin pain control.

- MOA: stimulates central opioid receptors, leading to pain relief, sedation, & euphoria, depresses the CNS, which slows HR & RR.

- Side effects:

common: constipation, sedation, nausea, & vomiting.

serious: respiratory depression and hypotension.

- Adverse effects: severe resp depression -> resp arrest and overdose risk (need naloxone (Narcan)).

- Pt education: "take only as prescribed", "pain relief is goal", "avoid alc & other sedatives", "don't operate heavy machinery", "store securely", "include fluid & fiber", "taper off".

- Nurse interventions: monitor rr closely, assess pain relief at peak (IV = 5-30 min), monitor for sedation/confusion, assess for overdose, and edu pt on opioid safety measures.

- Lifespan:

P: use with cation (weight based) and monitor for excessive sedation or resp distress.

A: standard dosing (pain severity), used for post-op surgical pain, trauma, & cancer pain.

G: increased risk of sedation, confusion, & falls, start with lower dose, & monitor for CNS depression.

2.     Opioid/APAP – hydrocodone-acetaminophen

- Pharm class: opioid analgesic (combo)

- Therapeutic use: moderate to severe pain (post-op pain, injury-related, chronic pain), combo of opioid & pain-reliever which enhances pain relief, and commonly prescribed for short-term pain management.

- MOA:

Opioid: binds to opioid receptors in CNS to alter pain perception.

APAP: inhibits prostaglandin synthesis in the CNS, reducing pain & fever.

- Side effects:

common: drowsiness, dizziness, nausea, vomiting, & constipation.

serious: resp depression, hypotension, liver toxicity.

- Adverse effects: severe resp depression -> resp failure, hepatoxicity (liver damage) if taken in excess doses (due to APAP), and OD risk.

- Pt education: "take only as prescribed", "max dose is 3 mg", "don't combine with other APAP", "avoid alc & other sedatives", "don't operate heavy machinery", "store securely and taper off", "report any signs of OD (slow RR, confusion, & severe drowsiness)"

- Nurse interventions: monitor RR, assess pain at peak (1 hr after oral dose), monitor liver function test (for APAP toxicity), monitor for sedation & confusion, increase fluids & fiber, administer naloxone if OD, and edu pt on safe med use.

- Lifespan:

P: use with caution - dose is weight based and monitor for excess sedation and resp depression.

A: standard dosing based on pain severity and used for post surgical pain, trauma, & moderate chronic pain.

3.     Antipyretic/Analgesic – acetaminophen

- Pharm class: non-opioid analgesic/antipyretic (APAP)

- Therapeutic use: mild to moderate pain relief & fever reduction, used for headaches, muscle pain, osteoarthritis, & fever management, and often combined with opioids to enhance pain relief.

- MOA: inhibits prostaglandin synthesis in CNS, reduces pain & fever and doesn't have anti-inflammatory properties like NSAIDs.

- Side effects: nausea, headache, & rash (rare)

- Adverse effects: hepatoxicity (liver damage) with OD or prolonged high doses and acute liver failure at doses exceeding 4g/day.

- Pt education: "take only as prescribed (3g/day) max (4g/day)", "avoid combining with other APAP", "avoid alc", and "report signs of liver toxicity (jaundice, nausea, dark urine, fatigue)"

- Nurse interventions: monitor liver function test in long term use, assess pain & relief effectiveness after administering, monitor for OD signs (nausea, confusion, jaundice, right-upper quadrant pain), edu pt about combining meds, and administer antidote if OD occurs (acetylcysteine).

- Lifespan:

P: safe when dosed by weight, common for fever & mild pain relief, avoid exceeding age-approp dosing guidelines.

A: commonly used for pain relief & fever reduction, monitor for cumulative APAP intake from other meds.

G: preferred over NSAIDs for pain relief due to lower risk of GI bleeding and liver function should be monitored in pt with liver disease or polypharm use.

4.     NSAID – ibuprofen

- Pharm class: NSAIDs

- Therapeutic use: mild to moderate pain relief, reduces inflammation & stiffness, reduction, & fever reducer. Used for chronic pain, arthritis, cramps, post-op pain, & headaches.

- MOA: inhibits cyclooxygenase (cox-1 & cox-2) enzymes, reducing prostaglandin synthesis, which decreases inflammation, pain, and fever.

- Side effects:

common: nausea, heartburn, dizziness, & headache,

GI effects: upset stomach, gastric irritation, and GI ulcers (overuse).

- Adverse effects: GI bleeding, peptic ulcers, perforation (long term use), increased cardiovascular risk (heart attack, stroke) with prolonged high-dose use, kidney damage (nephrotoxicity) in pts with pre-existing kidney disease.

- Pt education: "take with food or milk to reduce stomach irritation", "don't exceed recommended dose", "avoid alcohol", "monitor for signs of GI bleeding", "report symptoms of kidney damage", and "use cautiously with other NSAIDs or anticoagulants".

- Nurse interventions: monitor for GI symptoms (pain, heartburn, blood in stool), assess kidney function (BUN, creatine) for nephrotoxicity in prolonged use, monitor signs for cardiovascular complications (chest pain, shortness of breathe), and administer lowest effective dose for shortest duration.

- Lifespan:

P: used for fever & pain relief in children over 6 months and weight-based dosing.

A: commonly used for acute pain, chronic arthritis, & post surgical inflammation and monitor for long term side-effects, esp GI & cardiovascular risks.

G: higher risk for GI bleeding, kidney damage, & cardiovascular risks, use lowest effective dose and consider alternate pain management if needed.

5.     Anticonvulsants –

a.     Gabapentin & Pregabalin:

                                      i.     - Pharm class: anticonvulsant

                                    ii.     - Therapeutic use: used for neuropathic pain management: diabetic neuropathy, postherpetic neuroglia, sciatica, radiculopathy, phantom limb pain, fibromyalgia, & manage seizures.

                                  iii.     - MOA: modulates calcium channels in the nervous system, reducing nerve excitability, abnormal pain signaling, and doesn't directly block pain like opioids but decreases nerve pain perception over time.

                                   iv.     - Side effects: drowsiness, dizziness, fatigue, weight gain, & dry mouth.

                                    v.     - Adverse effects: severe CNS depression (excessive sedation, confusion), mood changes, difficulty concentrating, increase risk of suicidal thoughts, and peripheral edema (hands & feet).

                                   vi.     - Pt education: "taper off to avoid withdrawals", "take at same time daily", "may cause drowsiness/dizziness so avoid driving till effects are known", "monitor for mood changes/suicidal thoughts", "avoid alc & sedatives", "report swelling in hands/feet"

                                 vii.     - Nurse interventions: monitor pain relief effectiveness overtime, assess for CNS depression (sedation, confusion, dizziness), monitor kidney function (BUN, creatinine) in pt with renal impairment, and assess for mood changes/suicidal thoughts.

                               viii.     - Lifespan:

                                   ix.     P: monitor for mood changes and sedation.

                                    x.     A: chronic nerve pain conditions (sciatica, diabetes, fibromyalgia), required dose adjustments for kidney impairment.

                                   xi.     G: higher risk of dizziness, falls, & confusion. start with lower doses & monitor closely.

Disuse Syndrome:

1.     Identify the effects of immobility/disuse on each of the following body systems: 

·      Musculoskeletal: muscle atrophy and bone demineralization

·      Cardiovascular: venous stasis (swelling of lower extremities/increased work of the heart), increased cardiac workload, and decreased peripheral perfusion

·      Respiratory: reduced lung expansion, reduced movement of secretions, atelectasis, and reduced gas exchange capacity

·      Integumentary: decreased perfusion to tissues and increased pressure, friction, and shear

·      Neurological: psychological depression and poor sensation due to conditions causing immobility

·      Metabolic: increased catabolism (breakdown of protein) and fluid/electrolytes imbalances

·      Gastrointestinal/Genitourinary: decreased peristalsis and urine retention

2.     Discuss the clinical manifestations in each body system of the effects of immobility.

a.     Musculoskeletal: weakness and reduced range of motion (ROM)

b.     Cardiovascular: swelling of lower extremities, weaker pulses, and orthostatic hypotension

c.     Respiratory: hypoxemia/increased oxygen requirement, respiratory congestion/rhonchi, diminished/absent lung sounds in bases, increased respiratory rate, and weakened cough

d.     Integumentary: pallor and skin breakdown

e.     Neurological: depression and inability to report pain/discomfort accurately

f.      Metabolic:

g.     Gastrointestinal/Genitourinary: constipation and incontinence

3.     Discuss the complications of the effects of immobility on each of the body systems.

a.     Musculoskeletal: falls, permanent loss of function, contractures, and osteoporosis

b.     Cardiovascular: heart failure and kidney dysfunction

c.     Respiratory: pneumonia and respiratory failure

d.     Integumentary: pressure ulcers

e.     Neurological: untreated pain/depression/hopelessness, change in self-image, and loss of self-worth

f.      Metabolic: kidney damage

g.     Gastrointestinal/Genitourinary: anorexia, UTI, and skin breakdown due to incontinence

4.     Identify nursing interventions and collaborative interventions to prevent and treat the effects of immobility on each body system.

a.     Musculoskeletal: protective pain control

b.     Cardiovascular:

c.     Respiratory: frequent turning, early mobilization after operation/recovery, elevate head of bed, encouraging coughing/deep breathing, and incentive spirometry

d.     Integumentary: frequent turning, early mobilization after operation/recovery, special attention to pressure points, optimal positioning to reduce friction/shear (head of bed at 30 degrees and knees elevated), and frequent skin checks/cleaning

e.     Neurological: antidepressant therapy, therapy/counseling, optimize social/familial support, and maximize participation in society through accommodations

f.      Metabolic:

g.     Gastrointestinal/Genitourinary: stool softeners/laxatives, early mobilization, adequate hydration PO/IV, frequent turning, frequent skin care/cleaning, and barrier creams

5.     Differentiate between the physical and psychosocial negative consequences of impaired mobility. 

a.     Physical: direct impact on the body.

b.     Psychological: impact on mental, emotional, and social well-being.

6.     Define prophylaxis: an attempt to prevent disease.

Osteoporosis:

1.     Define osteoclast and osteoblast.

1. Osteoclast (bone reabsorption cells): break down and resorb bone by dissolving the mineral matrix.

2. Osteoblast (bone building cells): form new bones by producing collagen and mineralizing the bone matrix.

2.     Differentiate between osteoporosis and osteopenia.

2. Osteoporosis: reduced density of bone

3. Osteopenia: a precursor to osteoporosis

3.     Differentiate between modifiable and nonmodifiable risk factors for the patient with osteoporosis.

3. Modifiable: nutrition, weight, excess alcohol intake, caffeine intake, smoking, and long-term steroid use.

4. Non-modifiable: family history, postmenopausal women, and race (white and Asian)

4.     Describe clinical manifestations of osteoporosis and how it is diagnosed.

4. Asymptomatic until severe

5. Loss of height over time

6. Stooped posture – increased curvature of spine

7. Pathologic fracture: wrist, hip, and spine (back pain)

8. No pain

5.     Identify important teaching points for the patient with osteoporosis.

5. Complete regular follow-ups every 6 months, perform home safety measures, and repeat DEXA scan in 1-2 years

6.     Discuss pharmacological and non-pharmacological management of osteoporosis.

6. Pharm: bisphosphonates and post-menopausal estrogen

7. Non-pharm: weight-bearing exercise, resistance training, nutrition, vitamin D intake, and lifestyle modifications

7.     Define weight-bearing exercise: walking, swimming

Osteoarthritis:

1.     Describe the pathophysiology of osteoarthritis.

1. Erosion of cartilage in the joints due to excess joint use/weight

2.     Discuss modifiable and nonmodifiable risk factors for osteoarthritis. 

2. Modifiable: weight (obesity), occupation, physical activity/sports, diet, and injury

3. Non-modifiable: age, gender, genetics, and hormones

3.     Identify the most common clinical manifestations of osteoarthritis.

3. Pain, tenderness, swelling, redness, stiffness/loss of flexibility, grating sensation (crepitis), and bone spurs

4.     Discuss available collaborative therapies for treatment of osteoarthritis and their goals.

4. Physical/Occupational therapy

5.     Discuss important teaching points for the patient with osteoarthritis.

5. Pain increases with movement/exercise

6. Take medication (NSAID, APAP, SSRI/SNRI, or opioids) for pain/inflammation prior to movement/exercise

Hip Fracture:

1.     Discuss the different types of hip fractures and their locations and complications.

a.     Extrascapular: femoral shaft fractures in trochanter region.

b.     Intrascapular: within capsule of hip joint, femoral head fracture, femoral neck fracture, and may require total hip arthroplasty (THA)

2.     Identify modifiable and nonmodifiable risk factors for hip fracture.

a.     Modifiable: being immobile,

b.     Non-modifiable: age, post-menopausal women, chronic health problems

3.     Describe the clinical manifestations of hip fracture.

a.     Severe acute pain at site of fracture (worse with movement)

b.     Affected leg: shortened, externally rotated, loss of function, muscle spasms, swelling and discoloration/ecchymosis

c.     Neurovascular complications distal to fracture: change in pulses, sensation, and motor neurons

4.     Discuss the different complications of hip fracture and collaborative and independent nursing interventions to prevent each.

a.     DVT & PE:

                                      i.     Collab: administer anticoagulant, apply compression devices, and coordinate with physical therapy for early ambulation

                                    ii.     Independent: encourage exercise and repositioning, monitor for signs for DVT, and promote hydration

b.     Pressure ulcers:

                                      i.     Collab: collaborate with wound care specialists and use pressure-relieving mattresses or cushions

                                    ii.     Independent: turn and reposition patient every 2 hours and assess skin regularly and keep it dry

c.     Pneumonia & atelectasis:

                                      i.     Collab: collaborate with respiratory therapy for incentive spirometry

                                    ii.     Independent: encourage deep breathing and coughing exercises, elevate head of the bed to improve lung expansion, and encourage fluid intake and mobilization

d.     UTI & urinary retention:

                                      i.     Collab: limit indwelling catheter use; encourage early removal

                                    ii.     Independent: monitor output, encourage fluid intake, assist patient to bathroom or the bedside commode

e.     Constipation:

                                      i.     Collab: order stool softeners and laxatives and work with a dietitian for a fiber-rich diet

                                    ii.     Independent: encourage hydration and ambulation, monitor bowel movements, and promote high-fiber foods

5.     Define traction, internal fixation, and external fixation.

a.     Traction: a method used to align, immobilize, and reduce pain in fractures by applying pulling force to a limb.

b.     Internal fixation: a surgical procedure where screws, plates, rods, or nails are placed inside the bone to stabilize the fracture. It provides rigid fixation and allows earlier mobility.

c.     External fixation: a method where metal pins or screws are placed into the bone and connected to an external frame. It stabilizes fractures without opening the fracture site, reducing infection risk. Used for complex fractures, open fractures, or severe soft tissue damage.

6.     Discuss potential complications of internal fixation and how to prevent each. 

a.     Maintaining strict sterile technique during dressing changes.

b.     Promote early ambulation, use compression devices, and encourage leg exercises.

c.     Educate patients on activity restrictions.

d.     Monitor for pain, instability, or abnormal movement.

7.     Discuss nursing interventions to prevent complications of immobility after a hip fracture.

a.     Skin care, frequent repositioning, bed positioning (depends on type of surgery), incentive spirometry, assistive devices, rotational bed therapy, bed exercises (active and assistive ROM), and skin care

Joint Replacement (Total Hip Arthroplasty):

1.     Identify risk factors for THA.

a.     Osteoarthritis, trauma, severe joint pain or loss of function, congenital deformity, and joint degeneration due to rheumatoid arthritis

2.     Discuss complications of THA and collaborative and nursing interventions to prevent each.

a.     Bleeding:

                                                        i.     Collab: administer blood transfusions if needed, administer anticoagulants, monitor hemoglobin and hematocrit levels, and use wound drainage systems if excessive bleeding is present

                                                      ii.     Independent: monitor vital signs, monitor surgical site dressing for excess drainage, and educating patient on avoiding strenuous movement that could stress the incision.

b.     Dislocation of the hip prothesis:

                                                        i.     Collab: collaborative physical therapy, consult the orthopedic team, and ensure the use of a hip abduction pillow if prescribed

                                                      ii.     Independent: prevent excessive hip flexion (>90 degrees), adduction, or internal rotation, encourage use of raised toilet seats and chairs to prevent deep bending, teach the patient to avoid crossing their legs or twisting movements, and assess for shortened, externally rotated leg (sign of dislocation)

c.     VTE:

                                                        i.     Collab: administer anticoagulant, apply sequential compression devices or TED stockings, and collaborate with physical therapists for early ambulation.

                                                      ii.     Independent: encourage leg exercises, monitor calf pain, swelling, or warmth (DVT signs), assess for sudden chest pain or shortness of breath (PE signs), and encourage hydration to prevent clot formation.

d.     Infection:

                                                        i.     Collab: administer prophylactic antibiotics before and after surgery, monitor wound cultures if infection is suspected, and collaborate with wound care specialists for proper dressing changes.

                                                      ii.     Independent: maintain strict aseptic technique during dressing changes, monitor for redness, swelling, warmth, drainage, or fever, educate the patient on proper wound care and infection prevention, and encourage good nutrition to promote healing.

e.     Heel pressure injury:

                                                        i.     Collab: collaborate with wound care nurses and use pressure-relieving mattresses or heel protectors

                                                      ii.     Independent: reposition patient every 2 hours, offload pressure from heels, place pillows under calves to elevate them, keep skin clean, dry, and moisturized to prevent breakdown, and assess for redness, blanching, or open wounds.

f.      Heterotopic ossification:

                                                        i.     Collab: administer NSAIDs or radiation therapy if prescribed to prevent bone overgrowth and collaborate with orthopedic specialists for imagining and diagnosis.

                                                      ii.     Independent: assess for increasing pain, stiffness, and reduced range of motion, encourage gentle mobility exercises to prevent stiffness, and educate patients on the importance of continued physical therapy

3.     Identify correct positioning to minimize the risk of hip dislocation in the patient who is post-operative hip replacement (arthroplasty).

a.     Correct positioning using splint, wedge, and pillows

b.     Keep hip in abduction when turning, adduction when transferring

c.     Limited flexing of the hip; <90 degrees

4.     Apply all steps of the nursing process (including collaborative interventions) to manage pain in a patient who is post-operative hip fracture. ADPIE

a.     Assess the patients pain on a pain scale, the location, intensity, and quality, and assess for aggravating and alleviating factors. Monitor vital signs that would indicate pain, facial expressions, and the surgical site for swelling, hematoma, or signs of infection contributing to pain.

b.     Diagnosis: acute pain related to surgical trauma and muscle spasms, as evidenced by pain rating of X/10, grimacing, and guarding behavior.

c.     Planning: the goal is to have the patient's pain reduced within 30 minutes of intervention and will be comfortable during movement.

d.     Implementation:

                                                        i.     Collab: administer analgesics (opioids, NSAIDs, and acetaminophen), coordinate with physical therapists, and consult with pain management team.

                                                      ii.     Independent: use positioning techniques, apply cold therapy, encourage deep breathing exercises, and use distraction techniques.

e.     Evaluation: reassess pain level 30-60 minutes after intervention, monitor for side effects of pain medications, and adjust interventions based on patient response.

5.     Discuss nursing and collaborative interventions to prevent complications in post-operative THA patients.

a.     VTE:

                                                        i.     Collab: administer anticoagulants (enoxaparin, heparin), use SCDs & TED stockings.

                                                      ii.     Independent: encourage leg exercises, early ambulation, and monitor for calf pain/swelling.

b.     Infection prevention:

                                                        i.     Collab: administer prophylactic antibiotics and consult wound care for dressing changes.

                                                      ii.     Independent: maintain aseptic technique and assess for redness, drainage, and fever.

c.     Hip dislocation prevention:

                                                        i.     Collab: work with physical therapists for safe mobility training

                                                      ii.     Independent: use a hip abduction pillow and teach no bending >90 degrees or crossing legs

d.     Pressure injury prevention:

                                                        i.     Collab: consult wound care specialists for high-risk patients.

                                                      ii.     Independent: reposition every 2 hours, use heel protectors, and assess skin integrity

6.     Apply all steps of the nursing process (including collaborative interventions) to help prevent complications in the post-operative patient with hip fracture.

a.         Assess: Monitor vital signs, pain, circulation, sensation, and movement in the affected limb and assess for signs of VTE, infection, or pressure injuries.

b.     Diagnosis: risk for impaired mobility related to pain, surgical intervention, infection related to surgical site exposure, and complications (VTE, pressure injuries, and dislocation).

c.     Planning: patient will ambulate safely with assistance within 24-48 hours and remain free from infection and VTE.

d.     Implementation:

                                                        i.     Collab: work with PT & OT for early mobilization and assistive device training and administer DVT prophylaxis and pain medications.

                                                      ii.     Independent: Encourage incentive spirometry to prevent pneumonia. Perform neurovascular checks (pulses, cap refill, movement). Educate patient on proper movement restrictions

e.     Evaluation: monitor patient’s ability to move and participate in rehab and reassess for signs of infection, VTE, and pain relief effectiveness.

7.     Discuss appropriate early mobilization schedules for a patient following THA.

a.     Patients usually begin ambulation within 1 day after surgery using walker or crutches

b.     Weight bearing as prescribed by the physician

Medications: hip fracture/hip arthroplasty, impaired mobility, & osteoporosis:

1.     Anticoagulant – warfarin PO

- Pharm class: anti-coagulant/vitamin K antagonist

- Therapeutic use: prevent & treat blood clots in (DVT, PE, atrial fib (stroke), post-surg (THA/hip fracture) and long-term anti-coagulation (THA & hip fracture).

- MOA: inhibits the formation of vitamin K-dependent clotting factors and prevents new clot formation but doesn't dissolve existing clots.

- Side effects:

Common: bruising, prolonged bleeding, nausea, & headache

Serious: internal bleeding, hematuria, & black/tarry stools.

- Adverse effects: severe bleeding, hemorrhagic stroke, and skin necrosis (rare but serious).

- Pt education: "monitor INR levels", "maintain consistent diet with vit K (spinach & kale)", "report unusual bleeds (nose, gums, urine/stool)", "avoid NSAIDs & aspirin unless approved", "stop medication before invasive procedures"

- Nurse interventions: monitor INR/PT levels, assess for signs of bleeding, administer vit K if INR to high, ensure med is stopped before surgery.

- Lifespan:

P: rarely used but when used weight-based doses and frequent INR monitoring.

A: used for DVT/PE, atrial fib, & post-surg anti-coagulation and regular INR testing.

G: increased bleeding risk due to slower metabolism, lower starting doses, and frequent INR IVIS.

2.     Anticoagulant – apixaban

- Pharm class: factor Xa inhibitor

- Therapeutic use: prevents & treats blood clots in DVT, PE, Afib, & post-surg thromboprophylaxis (total knee/hip replacement)

- MOA: directly inhibits factor Xa that prevents thrombin formation and reduces the risk of clot formation in arteries & veins.

- Side effects: easy bruising, nausea, & minor bleeding.

- Adverse effects: severe GI bleeding or hemorrhage & spinal/epidural hematoma (risk if given before/after spinal anesthesia puncture).

- Pt education: "take at same time each day", "taper off", "monitor for signs of bleeding, headaches, dizziness", "avoid NSAIDs & aspirin", "no routine blood monitoring", "use soft toothbrush & electric razor"

- Nurse interventions: monitor for signs of bleeding, assess kidney function (BUN & creatine), ensure compliance with dosing sched

- Lifespan:

P: not commonly used so limited studies

A: preferred for DVT, PE, & afib - fixed dosing = no INR monitoring.

G: higher bleeding risk due to slow metabolism, renal impairment, and adjust dose based on kidney function.

3.     Bisphosphonates – alendronate

- Pharm class: biphosphate

- Therapeutic use: prevent and treats osteoporosis, post menopausal women (reduce fracture risk), increase bone density, and pt taking long-term corticosteroids prevents bone loss.

- MOA: inhibits osteoclast activity reducing bone resorption and increases bone mineral density (BMD) by slowing down bone loss.

- Side effects: nausea, abdominal pain, and musculoskeletal pain.

- Adverse effects: severe esophageal irritation or ulcers, osteonecrosis of the jaw (long term use), and atypical fractures of femur (rare cases).

- Pt education: "take in AM with full glass of water before eating", "remain upright for 30 min", "don't eat or drink for 30 mins after taking (except water)", "report severe heartburn or difficulty swallowing", "maintain calcium & vitamin D intake", "regular dental check-ups"

- Nurse interventions: monitor calcium levels, monitor BMD periodically, assess for musculoskeletal pain or atypical fractures, ensure proper admin technique, and encourage weight-bearing exercises.

- Lifespan:

P: not typically used.

A: common for osteoporosis prevention & treatment in high-risk adults.

G: high risk for esophageal irritation & fractures and proper admin technique crucial to avoid complications.

Benign Prostate Hyperplasia or Hypertrophy (BPH):

1.     Explain the pathophysiology of BPH.

a.     Progress condition characterized by enlargement of prostate gland due to complex hormonal and cellular interactions.

2.     Identify risk factors for development of BPH.

a.     Smoking

b.     Obesity

c.     Alcohol

d.     Hypertension

e.     Reduced physical activity

3.     Describe the signs and symptoms of BPH.

a.     Nocturia

b.     Urinary frequency – every 1-2 hours

c.     Urinary retention – incomplete bladder emptying (urine dribbles)

d.     Recurring UTIs

e.     Urinary amounts

f.      Pyelonephritis

g.     Acute kidney injury

h.     Fatigue

i.      Nausea

j.      Pelvic discomfort

4.     Identify changes in laboratory tests and diagnostic results in BPH.

a.     Cystoscopy

b.     Digital rectal exam (DRE)

c.     Prostate-specific antigen (PSA)

d.     Ultrasonography

e.     Uroflowmetry

f.      Urodynamic pressure

g.     Blood urine nitrogen (BUN)

5.     Discuss medical/surgical management of patients with BPH.

a.     med: meds to open urethra, reduce pain & spasms, catheters.

b.     surg: min invasive therapy, surgical resection, & transurethral resection of the prostate (TURP).

6.     Apply all steps of the nursing process in the care of a patient with BPH.

a.     Assess: interviewing patient history, urination frequency, and pain.

b.     Diagnosis: DRE, urinalysis, PSA, and BUN.

c.     Planning: maintain fluid volume balance, check-ups, medical management, and regular monitoring.

d.     Implement: promote urinary elimination (pee, wait, & try again), medications, educating the patient, and monitoring symptoms.

e.     Evaluate: discomfort and pain levels lower and no signs or symptoms of UTI or infections.

7.     Describe the complications of BPH.

a.     Kidney failure – chronic kidney disease

b.     Azotemia: accumulation of nitrogen waste products

c.     Urinary bladder stones

d.     Prostate cancer

e.     Stress

f.      Low self-esteem

g.     Low socialization

8.     Compare and contrast medications used for the treatment of BPH.

a.     Tamsulosin

                                      i.     - Pharm class: Alpha-Adrenergic Antagonist (Alpha Blocker)

                                    ii.     - Therapeutic use: lower urinary tract symptoms associated with BPH, can also be used for kidney stones, & management of BPH.

                                  iii.     - MOA: relaxes the smooth muscle in prostate and bladder to improve urine flow, reduces symptoms of BPH, alpha 1a receptors in prostate, & reduces high BP related effects.

                                   iv.     - Side effects: back pain, weakness, blurred vision, dizziness, nausea and nasal congestion.

                                    v.     - Adverse effects: sexual dysfunction, lower libido, diminished ejaculation, and orthostatic hypotension.

                                   vi.     - Pt education: "take at night to avoid falls", "no alc", "no driving until effects are known", "first dose has an increased fall risk", "careful combining with other antihypertensive meds"

                                 vii.     - Nurse interventions: monitor BP on first dose, monitor changes in urinary (frequency, flow, & urgency), administer after meals to improve absorption & minimize side effects, and patient counseling about potential sexual dysfunction.

                               viii.     - Lifespan:

                                   ix.     P: not typically used so limited date

                                    x.     A: effective in relieving BPH in males and monitor orthostatic hypotension in physically active adults.

                                   xi.     G: palpations and toxicity common in elderly men.

b.     Finasteride

                                      i.     - Pharm class: 5-alpha reductase inhibitor

                                    ii.     - Therapeutic use: lowers symptoms of BPH, lowers risk of urinary retention, mostly used in men, and can be used for alopecia.

                                  iii.     - MOA: blocks conversion of testosterone to DHT and reduces size of prostate which reduces BPH symptoms.

                                   iv.     - Side effects: decresed ejaculate volume, testicular pain, fatigue, and dizziness

                                    v.     - Adverse effects: breast tenderness, lowered libido, sexual dysfunction, diminished ejaculation, depression, gynecomastia, and hypersensitivity reaction.

                                   vi.     - Pt education: "may take 3-6 months to start working", "don't take with other vasodilators", "don't take if pregnant or breast feeding"

                                 vii.     - Nurse interventions: monitor urinary symptoms (flow, frequency, & urgency), monitor prostate size, assess sexual function, patient counseling about potential sexual dysfunction, and regular PSA testing (obtain baseline PSA before starting because it can mask prostate cancer).

                               viii.     - Lifespan:

                                   ix.     P: not typically used so limited data

                                    x.     A: effective in relieving BPH in males and monitor orthostatic hypotension in physically active adults.

                                   xi.     G: palpitations and toxicity common in elderly men.

Diarrhea/Bowel Incontinence:

1.     Identify risk factors for development of diarrhea/bowel incontinence.

a.     Infection

b.     Food intolerance

c.     Malabsorption

d.     Muscle weakness (anal sphincter)

2.     Describe the signs and symptoms of diarrhea/bowel incontinence.

a.     D – loose watery stools

b.     D – abdominal pain and bloating

c.     D – nausea and vomiting

d.     D – urgency to defecate

e.     BI – involuntary stool leakage due to lack of control

f.      BI – anal discomfort and irritation

g.     BI – feeling of incomplete evacuation

h.     Anorexia

i.      Borborygmus

j.      Tenesmus

3.     Identify changes in laboratory tests and diagnostic results in diarrhea/bowel incontinence.

a.     CT

b.     Urinalysis

c.     Endoscopy

d.     Manometry

e.     Abdominal x-ray

f.      Stool test

g.     CBC (anemia, infection)

h.     Defecography

4.     Discuss medical/surgical management of patients with diarrhea/bowel incontinence.

a.     Medical:

                                      i.     Replenish hydration

                                    ii.     Slow peristalsis

                                   iii.     Replenish electrolytes

b.     Surgical:

                                      i.     BI – Colostomy

                                    ii.     BI – Sphincteroplasty

                                   iii.     BI - Sacral nerve stimulation

                                   iv.     D - Stricture removal (Chron’s disease)

5.     Apply all steps of the nursing process in the care of a patient with diarrhea/bowel incontinence.

a.     Assess: interview the patient

b.     Diagnosis: run labs and diagnostics

c.     Planning: exercises, administering IVs, educating the patient, diet, and regular check-ups

d.     Implement: administering meds, bowel training, and monitoring frequency

e.     Evaluate: signs and symptoms decreasing or no signs

6.     Describe the complications of diarrhea/bowel incontinence.

a.     Dehydration

b.     Electrolyte imbalances

c.     Cardiac dysrhythmia

d.     Skin breakdown and infections

e.     Malnutrition

f.      Psychosocial issues (behavioral disorders)

7.     Compare and contrast medications used for the treatment of diarrhea/bowel incontinence. 

a.     Psyllium

                                      i.     - Pharm class: bulk-forming laxative

                                    ii.     - Therapeutic use: used for constipation, IBS, diverticulosis, stool regulation for diarrhea, and fecal ostomies, and support in blood sugar control for diabetes.

                                  iii.     - MOA: absorbs water in the intestines, forming a gel-like bulk the softens the stool and stimulates peristalsis which promotes bowel movements.

                                   iv.     - Side effects: abdominal bloating, flatulence, and mild cramping.

                                    v.     - Adverse effects: esophageal or intestinal obstruction (when taken with too little fluid intake), and allergic reactions (rare).

                                   vi.     - Pt education: "take with 8oz of water or juice & stay hydrated", "report difficulty swallowing, chest pain, & absence of bowel movements", "persistent diarrhea", "increase exercise and high-fiber foods"

                                 vii.     - Nurse interventions: monitor intake/output bowel function, retrosternal pain, and severe diarrhea/dehydration.

                               viii.     - Lifespan:

                                   ix.     P: approved for children 6 and up with supervision and ensure sufficient fluid intake.

                                    x.     A: safe for regular use when prescribed and diet/hydration changes.

                                   xi.     G: prevents constipation and close monitoring for dehydration/obstruction.

b.     Diphenoxylate/Atropine (Lomotil)

                                      i.     - Pharm class: opiate

                                    ii.     - Therapeutic use: management of diarrhea for acute or chronic.

                                  iii.     - MOA: slows GI mobility by binding to opioid receptors in the intestinal wall, reducing peristalsis, & increasing water absorption.

                                   iv.     - Side effects: dry mouth, drowsiness, dizziness, & nausea.

                                    v.     - Adverse effects: drowsiness, anticholinergic (dry mouth), constipation, & cardiac arrest.

                                   vi.     - Pt education: "don't operate heavy machinery", "sit/lay down if lightheaded", "change positions frequently", " suck on hard candy or chew gum", "sip water/clear liquids", "urinate every 4 hours & report any changes", "avoid caffeine"

                                 vii.     - Nurse interventions: monitor clients when ambulating, recommend low dose for long period of time, monitor for anticholinergic effects, monitor urination patterns.

                               viii.     - Lifespan:

                                   ix.     P: generally safe when used as directed, monitor for signs of CNS depression, and adherence to dosage recommendation.

                                    x.     G: use with caution due to increase risk of adverse effects (constipation, confusion, CNS depression), start with lower dosage, and monitor for drug interactions.

c.     Aluminum hydroxide

                                      i.     - Pharm class: antacid (tums)

                                    ii.     - Therapeutic use: treats gastric hyperacidity, treats GERD & PUD symptoms, and used to manage hyperphosphatemia in pts with chronic kidney disease.

                                  iii.     - MOA: neutralizes stomach acid by increasing pH of gastric contents and in hyperphosphatemia, it binds dietary phosphate in the GI tract, reducing serum phosphate levels.

                                   iv.     - Side effects: constipation, nausea, and Al taste.

                                    v.     - Adverse effects: hypophosphatemia (for prolonged use), osteomalacia (bone softening due to phosphate depletion), and Al toxicity especially in pts with impaired renal function.

                                   vi.     - Pt education: "increase fluid and fiber intake", "increase activity and exercise", "report abdominal pain and any severe diarrhea", "monitor sodium & phosphate intake", "report any signs of GI bleeding", "don't take meds within 1-2 hours of other meds"

                                 vii.     - Nurse interventions: monitor bowel functions, severe diarrhea, and phosphorus & magnesium levels, and administer stool softener

                               viii.     - Lifespan:

                                   ix.     P: use with caution and only under medical supervision. higher risk of phosphate depletion.

                                    x.     A: effective & widely used for acute and chronic conditions related to hyperacidity.

                                   xi.     G: use with caution because of the increased risk of constipation and phosphate depletion.

Clostridium Difficile (C. diff):

1.     Discuss evidence-based measures to prevent the spread of C. diff.

1. Wash hands thoroughly with soap and water.

2.     Explain the pathophysiology of C. diff.

2. Abnormal growth of C. diff in gut flora.

3.     Identify risk factors for development of C. diff.

3. Overuse of antibiotics

4.     Describe the signs and symptoms of C. diff.

4. Watery diarrhea

5. Loss of appetite

6. Abdominal pain and cramping

7. Fever

8. Dehydration

9. Nausea

10. Unresponsive to other treatments

5.     Identify changes in laboratory tests and diagnostic results in C. diff.

5. Stool samples

6. Colonoscopy

7. Blood tests

8. X-ray or CT scans

6.     Discuss medical/surgical management of patients with C. diff.

6. Appropriate antibiotic treatment

7. Fecal transplant

7.     Apply all steps of the nursing process in the care of a patient with C. diff.

7. Assess: antibiotic use, fever or malaise, history of hospitalization, frequent watery diarrhea, and abdominal pain or cramping

8. Diagnosis: impaired skin integrity, risk for infection transmission, electrolyte imbalance, excessive fluid loss, and diarrhea/watery stool

9. Planning: reduced diarrhea episodes, adequate hydration, understanding of infection preventions, and skin intact

10. Implement: infection control, fluid management, medications, skincare, and nutrition

11. Evaluate: stool consistency (decreased diarrhea), skin remains intact, no severe complications, and understating of patient education

8.     Describe the complications of C. diff.

8. Leukocytes

9. Colitis

10. Toxic megacolon

11. Sepsis

Constipation/Impaction:

1.     Explain the pathophysiology of constipation and impaction.

a.     C – slow/disrupt of normal bowel function

b.     I – hardened stool becomes stuck due to prolonged constipation

2.     Identify risk factors for development of constipation.

a.     low fiber & fluid intake, sedentary lifestyle.

3.     Explain how age-related changes put older adults at risk for constipation.

a.     weakened muscles, decreased physical activity, reduced fluid & fiber intake, slower guy motility.

4.     Describe the signs and symptoms of constipation.

a.     Fewer than 3 bowel movements a week

b.     Abdominal distension, pain, and bloating

c.     Straining of stool

d.     Elimination of small-volume, hard, dry stools

5.     Identify changes in laboratory tests and diagnostic results in constipation.

a.     Barium enema

b.     Sigmoidoscopy

c.     Stool testing

d.     Defecography

e.     Colonic transit studies

f.      MRI

6.     Discuss medical/surgical management of patients with constipation.

a.     Medication

b.     Disimpaction

c.     Enemas: tap water, saline, mineral oil, or lactulose

7.     Apply all steps of the nursing process in the care of a patient with constipation.

a.     Assess: infrequent bowel movements, straining, bloating, abdominal discomfort, hard dry stool, and medication history

b.     Diagnosis: constipation – decreased fiber intake, risk for fecal impaction, and acute pain in abdominal distension

c.     Planning: soft bowel movements, understanding diet, activity changes, adequate hydration, and relief from abdominal pain

d.     Implement: record bowel movements, monitor signs and fecal impaction, increase fluid and fiber intake, increase physical activity, toileting schedule, medications, and warm compress

e.     Evaluate: soft formed bowel movements, abdominal pain and bloating relieved, and no signs of fecal impaction

8.     Describe the complications of constipation, including impaction.

a.     Decreased cardiac output

b.     Fecal impaction

c.     Fissures

d.     Hemorrhoids

e.     Megacolon

f.      Rectal prolapse

9.     Describe the nonpharmacological treatments for impaction.

a.     increase fluids/water intake, physical activity, fiber intake (fruits & veggies).

Medications: BPH, diarrhea/bowel incontinence/GI upset, & constipation:

1.         bisacodyl, sennosides

a.         Pharm class: stimulant laxatives

b.         Therapeutic use:

                                                                           i.         Used for short-term relief of constipation and bowel impaction by stimulating bowel movements.

                                                                         ii.         Bowel cleaning

                                                                      iii.         Commonly used in preparation for surgeries or diagnostic procedures

                                                                      iv.         Sennosides can be used for opioid-induced constipation.

c.         MOA:

                                                                           i.         Stimulating the nerve endings in the walls of the colon, promoting peristalsis to move stool through intestines.

                                                                         ii.         Increases the secretion of water and electrolytes into the colon, which softens stool, making it easier to pass.

d.         Adverse effects:

                                                                           i.         Electrolyte imbalances (hypokalemia)

                                                                         ii.         Dehydration

                                                                      iii.         Severe abdominal cramping

                                                                      iv.         Colonic damage with overuse

                                                                         v.         Bowel dependency

                                                                      vi.         Melanosis coli with sennosides

e.         Side effects:

                                                                           i.         Diarrhea

                                                                         ii.         Abdominal cramping

                                                                      iii.         Bloating

                                                                      iv.         Nausea

                                                                         v.         Rectal irritation

                                                                      vi.         Mild dehydration

                                                                    vii.         Flatulence

f.            Patient education:

                                                                           i.         Use short-term

                                                                         ii.         Hydrate

                                                                      iii.         Administer properly

                                                                      iv.         Increase fiber

                                                                         v.         Monitor symptoms

                                                                      vi.         Avoid overuse

g.         Nursing interventions:

                                                                           i.         Monitor fluid/electrolyte balance

                                                                         ii.         Abdominal assessment

                                                                      iii.         Avoid long-term use

                                                                      iv.         Educate on correct use

                                                                         v.         Diet/activity recommendations

                                                                      vi.         Monitor for dependency

h.         Lifespan:

                                                                           i.         Pediatrics:

1.         Generally used when unresponsive to dietary changes or other treatments

2.         Dosage depends on weight – for bisacodyl 6 and older and for sennosides 2 and older

3.         Avoid long-term usage and frequent usage

                                                                         ii.         Adults:

1.         Short-term use for constipation when other treatments are ineffective

2.         For bisacodyl the dosage is 5-15mg orally or 10mg for suppositories

3.         For sennosides the dosage is 17.2mg once a day

4.         Monitor for dehydration, electrolytes, and dependency

                                                                      iii.         Geriatrics:

1.         At risk for dehydration, electrolyte imbalance, and bowel dependency

2.         Start with lowest effective dose

3.         Monitor patient with cardiovascular or kidney issues

2.         docusate sodium

a.         Pharm class: stool softener

b.         Therapeutic use:

                                                                           i.         Primarily used for relief in constipation, especially in cases where straining should be avoided (childbirth, after surgery).

                                                                         ii.         Used to prevent or treat stool impaction, typically in conjunction with other interventions like enemas.

c.         MOA:

                                                                           i.         Increases the water and fat content of the stool, making it softer and easier to pass.

                                                                         ii.         Reduces the surface tension of the stool, which allows water and lipids to penetrate the stool mass, softening it.

d.         Adverse effects:

                                                                           i.         Severe diarrhea or dehydration in overuse

                                                                         ii.         Electrolyte imbalances (hypokalemia or hyponatremia)

                                                                      iii.         Rectal bleed in rare cases

e.         Side effects:

                                                                           i.         Mild abdominal cramping

                                                                         ii.         Diarrhea

                                                                      iii.         Nausea

                                                                      iv.         Mild bloating

                                                                         v.         Flatulence

                                                                      vi.         Throat irritation in liquid form

f.            Patient education:

                                                                           i.         Use this short term

                                                                         ii.         Make sure to hydrate

                                                                      iii.         Dietary considerations

                                                                      iv.         Do not continue if you experience rectal bleeding or severe diarrhea

                                                                         v.         Caution with overuse

                                                                      vi.         Take orally with water

g.         Nursing interventions:

                                                                           i.         Monitor fluids/electrolytes

                                                                         ii.         Abdominal assessment

                                                                      iii.         Monitor for adverse effects

                                                                      iv.         Educate patients

h.         Lifespan:

                                                                           i.         Pediatrics:

1.         For children over 2 to avoid straining especially after surgery

2.         Low doses with monitoring

3.         Mostly used as liquid forms or suppository

4.         Avoid long term usage because it can lead to bowel dysfunction and dependency

                                                                         ii.         Adults:

1.         Short term for constipation

2.         50-400 mg daily orally or rectally

3.         Monitor for effectiveness and overuse dependency

                                                                      iii.         Geriatrics:

1.         Prone to dehydration, electrolyte imbalance especially with other meds

2.         Renal or cardiac conditions use cation

3.         Use lower doses because of frailty or health concerns monitor hydration/electrolytes

3.         polyethylene glycol 3350 (miraLAX):

a.         Pharm class: osmotic laxative

b.         Therapeutic use:

                                                                           i.         Used for constipation relief, particularly when other treatments aren’t sufficient.

                                                                         ii.         Used for long-term management

                                                                      iii.         Softens stool and increases bowel movement

                                                                      iv.         Cleanses the bowel before diagnostic procedures (colonoscopies)

c.         MOA:

                                                                           i.         Drawing water into colon through osmosis, which softens the stool and increases the frequency of bowel movements

                                                                         ii.         Hydrates the stool without significantly altering the body’s electrolytes, making it a safer long-term option compared to stimulant laxatives

d.         Adverse effects:

                                                                           i.         Severe dehydration

                                                                         ii.         Electrolyte imbalances (hypokalemia and hyponatremia)

                                                                      iii.         Severe diarrhea

                                                                      iv.         Bowel perforation (extremely rare)

                                                                         v.         Allergic reactions (rare)

e.         Side effects:

                                                                           i.         Abdominal bloating

                                                                         ii.         Flatulence

                                                                      iii.         Nausea

                                                                      iv.         Diarrhea

                                                                         v.         Mild abdominal discomfort

                                                                      vi.         Increased frequency of bowel movements

f.            Patient education:

                                                                           i.         Hydrate

                                                                         ii.         Mix powder with water one time a day

                                                                      iii.         Discontinue if severe diarrhea, cramping, abdominal discomfort

                                                                      iv.         Increase fiber

g.         Nursing interventions:

                                                                           i.         Monitor fluids/electrolytes

                                                                         ii.         Abdominal assessment

                                                                      iii.         Ensure proper administration

                                                                      iv.         Monitor for diarrhea

h.         Lifespan:

                                                                           i.         Pediatrics:

1.         Short term constipation for 2 years and up

2.         Dosage is based on weight

3.         Use with caution

4.         Hydrate

                                                                         ii.         Adults:

1.         Bowel cleaning prior to procedures and constipation

2.         17g of powder mixed with water

3.         May be used long term under supervision

4.         Monitor hydration/electrolytes

                                                                      iii.         Geriatrics:

1.         Monitor fluids/electrolytes especially with renal disease or heart failure

2.         Start with lowest dose

3.         Adequate hydration

4.         Long term use for chronic constipation under supervision

Impaired Mobility:

After a surgery this can result from pain, muscle weakness, joint stiffness, and increases the risk of complications like blood clots and muscle atrophy. The meds prescribed include analgesics, anticoagulants, opioid/APAP, NSAIDs, & opioids. Medications used: NSAIDS, opioid/APAP, anticoagulants, opioids, analgesics.

Urinary devices:

-              Indwelling (foley) catheter: short or long-term use (hours to weeks), inserted into the bladder via the urethra with a balloon to keep it in place, connected to a drainage bag, used for surgery, urinary retention, or chronic conditions. higher infection risk.

-              Intermittent (straight) catheter: short-term use (single-use, removed after bladder emptying), inserted only when needed, & reduces infection risk.

-              Suprapubic catheter: long-term use, inserted directly into the bladder through the lower abdomen, used when urethral catheterization is not possible, requires reg cleaning & care to prevent infections.

-              External (condom) catheter: non-invasive, fits over penis & connects to a drainage bag, used for incontinence but not retention issues, and has a lower infection risk.

-              Bedside toilets: a portable toilet that is placed near the bed for pts with limited mobility. used to ensure stability to prevent falls in post-op pts.

-              Bedpan: a shallow, curved bowl used for bowel movements & urination for pts who cannot get out of bed (immobile or bedridden, after surgeries, pts with spinal injuries or paralysis).

-              Urinals: a portable container designed for pts who have difficulty accessing the bathroom, used to collect urine while in bed or sitting. pts who are bedridden or limited mobility, post-op movement restrictions, or need assistance due to neurological conditions.

Age-related changes in elimination:

-              weakened pelvic floor muscles, reduced bladder capacity, decreased kidney function, prostate enlargement, slower peristalsis, decreased fluid & fiber intake, reduced sensation of bowel fullness.